Predictive role of FAS for trabectedin in second lines of advanced soft tissue sarcoma (ASTS): A Spanish group for research on sarcoma (GEIS) study.

被引：0
|
作者：
Broto, Javier Martin
Marcilla, David
Ramos, Rafael
Moura, David Silva
Alvarez, Ramiro
Hernandez, Nieves
Pujol, Carolina Agra
Mayordomo, Empar
Romagosa, Cleofe
Bague, Silvia
Reguero, Eugenia
Cruz, Julia
Martin, Francisco Javier
Gutierrez, Antonio
Cruz, Josefina
Alvarez, Rosa Maria Alvarez
Beveridge, Robert Diaz
Morales, Claudia Maria Valverde
Lopez-Pousa, Antonio
Martinez-Trufero, Javier
机构：
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2017年 / 35卷
关键词：
D O I：
10.1200/JCO.2017.35.15_suppl.11071
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
11071
引用
收藏
页数：5
相关论文
共 50 条
  • [41] Standard-dose doxorubicin versus sequential dose-dense doxorubicin and ifosfamide in patients with untreated advanced soft tissue sarcoma (ASTS): A GEIS Study
    Maurel, J.
    Lopez-Pousa, A.
    de las Penas, R.
    Fra, J.
    Cruz, J.
    Martin, J.
    Casado, A.
    Martinez-Trufero, J.
    Poveda, A.
    Garcia del Muro, X.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [42] Phase I trial of sorafenib in combination with ifosfamide in patients with advanced sarcoma: a Spanish group for research on sarcomas (GEIS) study
    Martin-Liberal, J.
    Lopez-Pousa, A.
    Martin Broto, J.
    Cubedo, R.
    Gallego, O.
    Brendel, E.
    Tirado, O. M.
    Garcia del Muro, X.
    INVESTIGATIONAL NEW DRUGS, 2014, 32 (02) : 287 - 294
  • [43] Phase Ib study of RG7112 with doxorubicin (D) in advanced soft tissue sarcoma (ASTS).
    Chawla, Sant P.
    Blay, Jean-Yves
    Italiano, Antoine
    Gutierrez, Martin
    Le Cesne, Axel
    Gomez-Roca, Carlos Alberto
    Gouw, Launce G.
    von Mehren, Margaret
    Wagner, Andrew
    Maki, Robert G.
    Higgins, Brian
    Middleton, Steven
    Nichols, Gwen L.
    Geho, David
    Blotner, Steven
    Zhi, Jianguo
    Chen, Lin Chi
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [44] Rechallenge with trabectedin in patients with locally advanced or metastatic soft tissue sarcoma following drug holiday: The experience of the French Sarcoma Group (FSG)
    Saada, Esma
    Rahal, Chahineze
    Coquard, Isabelle Ray
    Italiano, Antoine
    Chevreau, Christine
    Isambert, Nicolas
    Bui, Binh
    Cassar, Alexia
    Desmoulins, Isabelle
    Le Cesne, Axel
    Blay, Jean-Yves
    Thyss, Antoine
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [45] Prognostic factors of KIT-negative GIST-like patients (KNGL): A Spanish Group for Sarcoma Research (GEIS) study.
    Martin Broto, J.
    Garcia del Muro, X.
    Rubio, J.
    Gutierrez, A.
    Martinez-Trufero, J.
    Sevilla, I.
    Lainez, N.
    Andres, R.
    Ramos, R.
    Lopez-Guerrero, J. A.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [46] A noninterventional, multicenter, prospective phase IV study of trabectedin in patients with advanced soft tissue sarcoma
    Buonadonna, Angela
    Benson, Charlotte
    Casanova, Jose
    Kasper, Bernd
    Lopez Pousa, Antonio
    Mazzeo, Filomena
    Brodowicz, Thomas
    Penel, Nicolas
    ANTI-CANCER DRUGS, 2017, 28 (10) : 1157 - 1165
  • [47] Randomized Phase II Study of Trabectedin and Doxorubicin Compared With Doxorubicin Alone as First-Line Treatment in Patients With Advanced Soft Tissue Sarcomas: A Spanish Group for Research on Sarcoma Study
    Martin-Broto, Javier
    Lopez Pousa, Antonio
    de las Penas, Ramon
    Garcia del Muro, Xavier
    Gutierrez, Antonio
    Martinez-Trufero, Javier
    Cruz, Josefina
    Alvarez, Rosa
    Cubedo, Ricardo
    Redondo, Andres
    Maurel, Joan
    Carrasco, Juan A.
    Lopez-Martin, Jose A.
    Sala, Angeles
    Andres Meana, Jose
    Ramos, Rafael
    Martinez-Serra, Jordi
    Lopez-Guerrero, Jose A.
    Sevilla, Isabel
    Balana, Carmen
    Vaz, Angeles
    De Juan, Ana
    Alemany, Regina
    Poveda, Andres
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (19) : 2294 - +
  • [48] Neoadjuvant chemotherapy in high-risk soft tissue sarcomas: Final results of a randomized clinical trial from the Italian Sarcoma Group, the Spanish Sarcoma Group (GEIS), the French Sarcoma Group (FSG), and the Polish Sarcoma Group (PSG).
    Gronchi, Alessandro
    Palmerini, Emanuela
    Quagliuolo, Vittorio
    Broto, Javier Martin
    Pousa, Antonio Lopez
    Grignani, Giovanni
    Brunello, Antonella
    Blay, Jean-Yves
    Beveridge, Robert Diaz
    Ferraresi, Virginia
    Lugowska, Iwona
    Merlo, Franco Domenico
    Fontana, Valeria
    Palassini, Elena
    Morosi, Carlo
    Stacchiotti, Silvia
    Dei Tos, Angelo Paolo
    Picci, Piero
    Bruzzi, Paolo
    Casali, Paolo Giovanni
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [49] Adjuvant treatment of GIST with imatinib: Solid ground or still quicksand? A comment on behalf of the EORTC Soft Tissue and Bone Sarcoma Group, the Italian Sarcoma Group, the NCRI Sarcoma Clinical Studies Group (UK), the Japanese Study Group on GIST, the French Sarcoma Group and the Spanish Sarcoma Group (GEIS)
    Gronchi, Alessandro
    Judson, Ian
    Nishida, Toshirou
    Poveda, Andres
    Martin, Javier
    Reichardt, Peter
    Casali, Paolo G.
    Le Cesne, Axel
    Hohenberger, Peter
    Blay, Jean-Yves
    EUROPEAN JOURNAL OF CANCER, 2009, 45 (07) : 1103 - 1106
  • [50] Trabectedin for patients with advanced soft tissue sarcoma: A non-interventional, prospective, multicenter study
    Grunwald, V.
    Pink, D.
    Egerer, G.
    Schalk, E.
    Augustin, M.
    Deinzer, C. K.
    Kob, V.
    Reichert, D.
    Kebenko, M.
    Brandl, S. F.
    Hahn, D. A.
    Lindner, L. H.
    Hoiczyk, M.
    Ringsdorf, U.
    Hanker, L.
    Hempel, D.
    Pontes, M. J.
    Wismann, T.
    Ivanyi, P.
    ANNALS OF ONCOLOGY, 2022, 33 (07) : S1231 - S1231
12345